**Breadth of Evaluation.** Our chosen axes of evaluation were not exhaustive and their interpretation was often subjective in nature. Although we conducted evaluations from both clinician and lay-perspectives, generating scenario-packs in three countries with assessors in both North America and India, the pool of clinicians and lay-people assessing the models could be expanded further to improve generalization of our insights. Our experiments could also undergo more extensive replication to explore other aspects such as inter-observer and inter-participant variability, including future work with an intentionally further diversified pool of human raters (clinicians and lay users). Participatory design in the development of model evaluation tools with a representative pool of patients, as well as clinical and health equity domain experts, could also be valuable.